X

Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
NOT-DK-12-005: Notice of Detailed Budget Correction for NIDDK PAR-11-349: Research Using Subjects From The Type 1 Diabetes TrialNet Natural History Study (Living Biobank) (DP3) and PAR-11-350: Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3)

Notice of Detailed Budget Correction for NIDDK PAR-11-349: Research Using Subjects From The Type 1 Diabetes TrialNet Natural History Study (Living Biobank) (DP3) and PAR-11-350: Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3)


Notice Number:  NOT-DK-12-005

Key Dates

Release Date:  December 1, 2011

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice amends Section II. Award Information, Award Budget Section for NIDDK  PAR-11-349: Research Using Subjects From The Type 1 Diabetes TrialNet Natural History Study (Living Biobank) (DP3)  and PAR-11-350: Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3) provides additional instructions regarding the budgeting of consortium and contractual costs and Just In Time submissions.  The following two statements apply to both FOAs: 

1. Facilities and Administrative (F&A) costs requested by consortium participants are not included in the direct cost limitation. See NOT-OD-05-004.

2. This FOA uses "Just-In-Time" information concepts (see see SF424 (R&R) Application Guide).  Detailed budget information will be request as part of the Just-In-Time information.

This Notice also amends Section IV.2. Content and Form of Application Submission, for PAR-11-349: Research Using Subjects From The Type 1 Diabetes TrialNet Natural History Study (Living Biobank) (DP3)  and PAR-11-350: Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3) provides additional instructions regarding the submission of budgetary information.  The following information should be added:

SF424 (R&R) Cover component

All other aspects of the FOAs remain unchanged.  

Inquiries

Please direct all inquiries to:

Lisa M. Spain, Ph.D.
Division of Diabetes, Endocrinology and Metabolic Diseases (DEM)
National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)
6707 Democracy Boulevard
Bethesda, MD 20817
(301)451-9871
spainl@niddk.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.